Top Clinical Trials companies in South Korea by Dividend Per Share
South Korea
# |
Name |
Dividend Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -0.00
|
Dec. 31, 2023 | USD 1.67 | -1.86% |
|
South Korea |
|
| 2 |
USD -0.00
|
Dec. 31, 2023 | USD 17.25 | 0.74% |
|
South Korea |
|
| 3 |
USD -0.00
|
Dec. 31, 2023 | USD 3.70 | 0.18% |
|
South Korea |
|
| 4 |
USD -0.00
|
Dec. 31, 2023 | USD 10.57 | -0.48% |
|
South Korea |
|
| 5 |
USD -0.00
|
Dec. 31, 2023 | USD 1.17 | -3.48% |
|
South Korea |
|
| 6 |
USD -0.00
|
Dec. 31, 2023 | USD 3.10 | -1.75% |
|
South Korea |
|
| 7 |
USD -0.00
|
Dec. 31, 2023 | USD 21.07 | 1.40% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Dividend Per Share ?
The Clinical Trials company in South Korea with the highest Dividend Per Share is GeneOne Life Science, Inc. (KSE: 011000.KS) at USD -0.00.
-
Which Clinical Trials company in South Korea has the lowest Dividend Per Share ?
The Clinical Trials company in South Korea with the lowest Dividend Per Share is ABL Bio Inc. (KOSDAQ: 298380.KQ) at USD -0.00.
-
What are the top 10 Clinical Trials companies in South Korea by Dividend Per Share ?
The top 10 Clinical Trials companies in South Korea by Dividend Per Share are GeneOne Life Science, Inc., Oscotec Inc., Genexine, Inc., OliX Pharmaceuticals,Inc, Gencurix Inc., MedPacto, Inc. and ABL Bio Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Dividend Per Share ?
The bottom 10 Clinical Trials companies in South Korea by Dividend Per Share are ABL Bio Inc., MedPacto, Inc., Gencurix Inc., OliX Pharmaceuticals,Inc, Genexine, Inc., Oscotec Inc. and GeneOne Life Science, Inc..